Ruxolitinib for Acute Graft-versus-Host Disease. Reply

Robert Zeiser; Nikolas von Bubnoff; Gérard Socié

doi:10.1056/NEJMc2020763

Ruxolitinib for Acute Graft-versus-Host Disease. Reply

Robert Zeiser, Nikolas von Bubnoff, Gérard Socié

Department of Hematology and Oncology

Original language	English
Journal	The New England journal of medicine
Volume	383
Issue number	5
ISSN	0028-4793
DOIs	https://doi.org/10.1056/NEJMc2020763
Publication status	Published - 30.07.2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1056/NEJMc2020763

Cite this

@article{a07a5a220bf14ac2b5d3028e15f493a6,

title = "Ruxolitinib for Acute Graft-versus-Host Disease. Reply",

author = "Robert Zeiser and \{von Bubnoff\}, Nikolas and G{\'e}rard Soci{\'e}",

note = "Copyright: This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine",

year = "2020",

month = jul,

day = "30",

doi = "10.1056/NEJMc2020763",

language = "English",

volume = "383",

journal = "The New England journal of medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "5",

}

TY - JOUR

T1 - Ruxolitinib for Acute Graft-versus-Host Disease. Reply

AU - Zeiser, Robert

AU - von Bubnoff, Nikolas

AU - Socié, Gérard

N1 - Copyright: This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine

PY - 2020/7/30

Y1 - 2020/7/30

UR - https://www.scopus.com/pages/publications/85088852240

U2 - 10.1056/NEJMc2020763

DO - 10.1056/NEJMc2020763

M3 - Letters

C2 - 32726542

AN - SCOPUS:85088852240

SN - 0028-4793

VL - 383

JO - The New England journal of medicine

JF - The New England journal of medicine

IS - 5

ER -

Ruxolitinib for Acute Graft-versus-Host Disease. Reply

UN SDGs

Access to Document

Other files and links

Cite this